To determine the cytotoxicity of MAGE-D4-specific T cells, the expression of immunomarkers in CD8+ T cells induced by MAGE-D4-specific DC was detected by flow cytometry and ELISA in epigenetic drug-treated glioma cells. Here, MAGED4 is linked to central nervous system cancer.